Type Société Anonyme Founder Alain Mérieux Headquarters Marcy-l'Étoile, France Number of employees 8,935 | Traded as Euronext: BIM Area served Worldwide Revenue 169 billion EUR (2014) | |
 | ||
Founded 1963; 54 years ago (1963) Key people Jean-Luc Bélingard
(CEO)
Alexandre Mérieux
(Chairman)
Marcel Mérieux, Charles Mérieux Stock price BIM (EPA) € 145.80 +0.70 (+0.48%)1 Mar, 5:35 PM GMT+1 - Disclaimer CEO Alexandre Merieux (Apr 2014–) Profiles | ||
bioMérieux (Euronext: BIM) is a multinational biotechnology company founded and headquartered in France. bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors.
Contents
bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the NYSE Euronext Paris stock exchange (BIM – ISIN: FR0010096479).
Revenue
bioMérieux has revenues of €1.698 billion as of 2014 with 88% of sales occurring outside France.